Kymera Therapeutics, Inc. Common Stock KYMR
$117.39
+2.60%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 10-Q | 10-Q | 2026-08-05 | View → |
| 8-K | 8-K | 2026-08-05 | View → |
| 4 | 4 | 2026-07-27 | View → |
| 8-K | 8-K | 2026-07-27 | View → |
| 4 | 4 | 2026-07-07 | View → |
| 4 | 4 | 2026-07-02 | View → |
| 4 | 4 | 2026-07-02 | View → |
| 4 | 4 | 2026-07-02 | View → |
| 4 | Insider transaction | 2026-06-30 | View → |
| 4 | Insider transaction | 2026-06-30 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-06-26 | View → |
| 4 | Insider transaction | 2026-06-25 | View → |
| 4 | Insider transaction | 2026-06-25 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-06-25 | View → |
| 4 | 4 | 2026-06-25 | View → |
| 4 | 4 | 2026-06-25 | View → |
| 4 | 4 | 2026-06-25 | View → |
| 4 | 4 | 2026-06-25 | View → |
| 4 | 4 | 2026-06-25 | View → |
| 4 | 4 | 2026-06-25 | View → |
| 4 | 4 | 2026-06-25 | View → |
| 4 | 4 | 2026-06-25 | View → |
| 4 | 4 | 2026-06-25 | View → |
| 8-K | 8-K | 2026-06-25 | View → |
| 8-K | 8-K | 2026-06-24 | View → |
| 4 | Insider transaction | 2026-06-22 | View → |
| 4 | Insider transaction | 2026-06-22 | View → |
| 4 | 4 | 2026-06-22 | View → |
| 8-K | 8-K | 2026-06-08 | View → |
| 4 | 4 | 2026-06-03 | View → |
| 4 | 4 | 2026-05-27 | View → |
| 4 | 4 | 2026-05-19 | View → |
| 4 | 4 | 2026-05-19 | View → |
| 4 | 4 | 2026-05-11 | View → |
| 10-Q | 10-Q | 2026-04-30 | View → |
| 8-K | 8-K | 2026-04-30 | View → |
| 4 | 4 | 2026-04-29 | View → |
| DEF 14A | DEF 14A | 2026-04-29 | View → |
| 4 | Insider transaction | 2026-04-24 | View → |
| 4 | 4 | 2026-04-24 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $117.39
- Market Cap
- $9.48 billion
- 52-Week Range
- $36.65 – $130.05
- Average Volume
- 646K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.